These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 8262880)

  • 1. Divalproex sodium in the treatment of refractory affective disorders.
    Schaff MR; Fawcett J; Zajecka JM
    J Clin Psychiatry; 1993 Oct; 54(10):380-4. PubMed ID: 8262880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A medication algorithm for treatment of bipolar rapid cycling?
    Calabrese JR; Woyshville MJ
    J Clin Psychiatry; 1995; 56 Suppl 3():11-8. PubMed ID: 7883737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126).
    Vieta E; Suppes T; Eggens I; Persson I; Paulsson B; Brecher M
    J Affect Disord; 2008 Aug; 109(3):251-63. PubMed ID: 18579216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to divalproex and lithium.
    Bowden CL
    J Clin Psychiatry; 1995; 56 Suppl 3():25-30. PubMed ID: 7883739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders.
    Tohen M; Castillo J; Pope HG; Herbstein J
    J Clin Psychopharmacol; 1994 Feb; 14(1):67-70. PubMed ID: 8151006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mood-stabilizing drugs in depression.
    Shelton RC
    J Clin Psychiatry; 1999; 60 Suppl 5():37-40; discussion 41-2. PubMed ID: 10192406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenomenology of rapid cycling manic depression and its treatment with valproate.
    Calabrese JR; Delucchi GA
    J Clin Psychiatry; 1989 Mar; 50 Suppl():30-4. PubMed ID: 2494157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment guidelines for valproate in bipolar and schizoaffective disorders.
    McElroy SL; Keck PE
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S62-6. PubMed ID: 8500081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar rapid cycling: focus on depression as its hallmark.
    Calabrese JR; Shelton MD; Bowden CL; Rapport DJ; Suppes T; Shirley ER; Kimmel SE; Caban SJ
    J Clin Psychiatry; 2001; 62 Suppl 14():34-41. PubMed ID: 11469674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging perspectives on valproate in affective disorders.
    Post RM
    J Clin Psychiatry; 1989 Mar; 50 Suppl():3-9. PubMed ID: 2494156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of rapid-cycling bipolar disorder.
    Schneck CD
    J Clin Psychiatry; 2006; 67 Suppl 11():22-7. PubMed ID: 17029493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.